Skip to content

Examination of odor perception and emotion changes in patients undergoing chemotherapy

Examination of odor perception and emotion changes in patients undergoing chemotherapy - Examination of odor perception and emotion changes in patients undergoing chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014285
Enrollment
10
Registered
2014-06-18
Start date
2014-06-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive cancer

Interventions

The subjects perform in the same patient, the intervention times of the examination of odor perception and emotion are at the three times that are ago, during, after the anticancer drug administration

Sponsors

National Hospital Higashi Hiroshima Medical Center
Lead Sponsor
National Hospital Higashi Hiroshima Medical Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inpatients, communication does not have a hindrance, are adults who are treated with the digestive cancer chemotherapy, and are available for oral intake , and 20 years-old or older.

Exclusion criteria

Exclusion criteria: The persons except the key inclusion criteria

Design outcomes

Primary

MeasureTime frame
Odor Stick Identification Test for Japanese(OSIT-J) The intervention times of the examination of odor perception are at the three times that are ago, during, after the anticancer drug administration in one anticancer drug treatment course.

Secondary

MeasureTime frame
1.Visual Analogue Scale(VAS) estimating emotion affected by odor perception 2. physiological indicators temperature, percutaneous oxygen saturation of the arterial blood, a pulse rate, blood pressure 3. Biochemical examination of blood Alb, Hgb, Hct, RBC, WBC, Lympho, Plt, MCV, Cr, BUN, FBS, AST, ALT, Na 4. The questionnaire writing by oneself about the smell The intervention times are at the three times that are ago, during, after the anticancer drug administration in one anticancer drug treatment course. However,we do not perform the biochemical examination of blood during treatment with anticancer drug.

Countries

Japan

Contacts

Public ContactKojiro Ishinaga

Graduate School of Biomedical and Health Sciences, Hiroshima University Psychosocial Rehabilitation Laboratory

koujirou@gaines.hju.ac.jp082-555-8265

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026